Literature DB >> 8195698

Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats--analysis of mechanisms of lethality in endotoxemia.

Y Iimuro1, M Yamamoto, H Kohno, J Itakura, H Fujii, Y Matsumoto.   

Abstract

We investigated the effects of gadolinium chloride (GdCl3.6H2O), which blocks phagocytosis by liver macrophages, on the mortality, blood tumor necrosis factor (TNF) levels, and hepatotoxicity in a lethal endotoxic shock rat model system [10 mg/kg body weight lipopolysaccharide (LPS) intravenously]. With administration of GdCl3, twice at 0.5 or 5 mg/kg, the survival rate 24 h after LPS injection was 56% and 100%, respectively, whereas the level of TNF in blood was not affected. Microscopic investigation of the liver revealed that the focal necrosis of hepatocytes under endotoxemia was completely protected by the administration of GdCl3 at 5 mg/kg. We then investigated the effects of GdCl3 on superoxide (O2-) production by isolated liver macrophages in vitro. The O2- production by liver macrophages isolated from control rats was suppressed by GdCl3 in a dose-dependent manner. GdCl3 also had a cytotoxic effect on these macrophages. The enhanced O2- production by liver macrophages isolated from sublethal endotoxemic (1 mg/kg) rats was suppressed by pretreatment with GdCl3 (5 mg/kg). It was suggested that lethality in endotoxemia cannot be explained only by the degree of increase in blood TNF levels and that the mechanism by which GdCl3 reduces mortality and hepatotoxicity in endotoxemia possibly includes suppression of superoxide production by liver macrophages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195698     DOI: 10.1002/jlb.55.6.723

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.

Authors:  J K Olynyk; G C Yeoh; G A Ramm; S L Clarke; P M Hall; R S Britton; B R Bacon; T F Tracy
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation.

Authors:  H Chiao; S Foster; R Thomas; J Lipton; R A Star
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

4.  Aging results in accumulation of M1 and M2 hepatic macrophages and a differential response to gadolinium chloride.

Authors:  Steven A Bloomer; Eric D Moyer; Kyle E Brown; Kevin C Kregel
Journal:  Histochem Cell Biol       Date:  2019-11-06       Impact factor: 4.304

5.  Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo.

Authors:  Parmeswaran Diagaradjane; Amit Deorukhkar; Juri G Gelovani; Dipen M Maru; Sunil Krishnan
Journal:  ACS Nano       Date:  2010-07-27       Impact factor: 15.881

6.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

Review 7.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

Review 8.  Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

Authors:  Keisaku Sato; Chad Hall; Shannon Glaser; Heather Francis; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2016-07-22       Impact factor: 4.307

Review 9.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Gadolinium decreases inflammation related to myocardial ischemia and reperfusion injury.

Authors:  Jennifer L Strande; Kasi V Routhu; Anna Hsu; Alfred C Nicolosi; John E Baker
Journal:  J Inflamm (Lond)       Date:  2009-12-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.